| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 966.62B | 796.67B | 788.87B | 938.10B | 865.17B |
| Gross Profit | 202.83B | 172.78B | 165.25B | 191.06B | 169.73B |
| EBITDA | 90.68B | 84.11B | 78.79B | 91.14B | 81.33B |
| Net Income | 24.25B | 10.65B | 8.50B | 18.41B | 16.59B |
Balance Sheet | |||||
| Total Assets | 1.25T | 1.22T | 1.30T | 1.23T | 1.23T |
| Cash, Cash Equivalents and Short-Term Investments | 142.74B | 201.04B | 195.66B | 161.70B | 139.16B |
| Total Debt | 220.06B | 306.40B | 318.94B | 360.81B | 327.21B |
| Total Liabilities | 550.01B | 550.35B | 620.12B | 598.53B | 597.09B |
| Stockholders Equity | 674.89B | 651.46B | 659.98B | 616.21B | 617.80B |
Cash Flow | |||||
| Free Cash Flow | 63.38B | 31.82B | 41.12B | 12.41B | -13.33B |
| Operating Cash Flow | 103.70B | 82.18B | 99.82B | 64.16B | 22.73B |
| Investing Cash Flow | -68.66B | -58.75B | -90.81B | -48.78B | -19.97B |
| Financing Cash Flow | -40.07B | -33.74B | -24.78B | 4.42B | -48.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.03B | 19.91 | 11.08% | 0.57% | -2.04% | -43.19% | |
69 Neutral | $3.66B | 22.33 | 3.07% | 3.30% | 15.45% | 115.63% | |
68 Neutral | $6.23B | 9.05 | -42.77% | 1.49% | 7.36% | 34.94% | |
68 Neutral | $2.77B | 17.90 | 8.88% | 1.77% | 6.86% | 104.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | $3.70B | -8.89 | -12.67% | 1.70% | -23.37% | -131.29% | |
44 Neutral | $1.69B | -1.92 | -58.09% | ― | -3.69% | -958.22% |